The Alcohol and Tobacco Tax and Trade Bureau (TTB) made a new ruling on how alcohol products can be labeled with respect to gluten. The TTB’s revised ruling on the matter, for the most part, is in line with the FDA.
A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.
Celiac Disease Foundation is pleased to partner with Quest Diagnostics in Quest’s “One symptom doesn’t define celiac disease. But one test can.” campaign. Join with CDF to Consider Celiac and Request the Test.
Celiac disease, one of the most common autoimmune diseases in the world today, often goes undiagnosed due to asymptomatic patients and many nonspecific symptoms. To diagnose a patient with celiac disease, a positive intestinal biopsy is typically necessary. But when physicians need to decide on whether or not to order a biopsy, they have many […]
Woodland Hills, CA; February 18, 2014 — Celiac Disease Foundation (CDF) today released an interactive checklist to help individuals and families accurately define and report their symptoms of celiac disease and gluten sensitivity to their doctor or other health care practitioner. This checklist not only will help individuals have more clear conversations with their healthcare providers, it will help more people with celiac disease get the proper diagnosis. This free checklist, developed with the CDF Medical Advisory Board, can be accessed at celiac.org/symptoms.